KWB Wealth’s Lexicon Pharmaceuticals LXRX Stock Holding History

KWB Wealth’s Portfolio LXRX Stock Details LXRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-40,640	Closed	-$46.7K	–	178
2026 Q1	$46.7K	Hold	40,640	–	–	﹤0.01%	166
2025 Q4	$46.7K	Hold	40,640	–	–	﹤0.01%	175
2025 Q3	$38.4K	Hold	40,640	–	–	﹤0.01%	147
2025 Q2	$18.7K	Hold	40,640	–	–	﹤0.01%	156
2025 Q1	$30K	Hold	40,640	–	–	﹤0.01%	149
2024 Q4	$63.8K	Hold	40,640	–	–	0.01%	140
2024 Q3	$68.3K	Hold	40,640	–	–	0.01%	131
2024 Q2	$97.5K	Hold	40,640	–	–	0.01%	129
2024 Q1	$97.5K	Hold	40,640	–	–	0.01%	129
2023 Q4	$62.2K	Buy	+40,640	New	+$48.3K	0.01%	128

Other funds holding LXRX

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

MPWT

MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return

HPC

HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

KWB Wealth's LXRX Position: Q2 2026 in Review

KWB Wealth sold out of Lexicon Pharmaceuticals (LXRX) in Q2 2026, closing a stake of 40,640 shares — an estimated $46.7K sold.

KWB Wealth first reported a position in LXRX in Q4 2023 and held it in 10 quarters. The position peaked at $97.5K in Q2 2024. 4 funds tracked by Wall St. Rank hold LXRX as of Q2 2026.

KWB Wealth reported no remaining Lexicon Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
KWB Wealth sold 40,640 Lexicon Pharmaceuticals shares in Q2 2026, an estimated $46.7K.
KWB Wealth first reported a position in Lexicon Pharmaceuticals in Q4 2023 and held it in 10 quarters.
KWB Wealth's Lexicon Pharmaceuticals position peaked at $97.5K in Q2 2024.
4 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q2 2026.

Based on KWB Wealth's 13F filing for Q2 2026, filed 10 Jul 2026.